Real-world effectiveness and safety of olaparib in HRD-positive BRCA wild-type ovarian cancer

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting following first-line chemotherapy.

First gene therapies for sickle cell disease secure FDA approval – Pharmaceutical Technology

Share this article More than 100,000 people live with sickle cell disease in the US, with the most patients being African American. Image credit: Shutterstock/Ezume

December 11, 2023

Education boosts well-being, but intelligence can bring you down, study suggests

Study explores causal relationships between educational attainment, intelligence, and well-being, revealing that while education positively impacts well-being, higher intelligence may have a negative effect.

May 14, 2024

Rethinking mental health research through AI-driven simulations

Recent research highlights generative agents’ potential to model complex socio-environmental interactions, transforming mental health studies and interventions.

January 20, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.